ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1580

The Relationship Between Perceived Cognitive Dysfunction and Objective Neuropsychological Performance in Persons with Rheumatoid Arthritis

So Young Shin1, Patricia P. Katz2 and Laura J. Julian2, 1Physiological Nursing, University of California San Francisco, San Francisco, CA, 2Medicine, University of California San Francisco, San Francisco, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cognitive dysfunction and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rehabilitation Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose: There is an increased appreciation of the burden of cognitive impairment in persons with rheumatoid arthritis (RA). Research shows a gap between perceived cognitive dysfunction and objective neuropsychological performance in persons with chronic diseases. This study explored this relationship in persons with RA.

Methods: Individuals from a longitudinal cohort study of RA participated in a study visit that included physical, psychosocial, and biological metrics. Subjective cognitive dysfunction was assessed using the Perceived Deficits Questionnaire (PDQ; range 0-20, higher score=greater impairment). Objective cognitive impairment was assessed using a battery of 12 standardized neuropsychological measures yielding 16 indices. On each test, subjects were classified as ‘impaired’ if they performed 1 SD below age-based population norms. A total cognitive impairment score (range 0-16) was calculated by summing the transformed scores (higher score=worst impairment). Multiple regression analyses controlling for gender, race, marital status, income, education, disease duration, disease severity, depression, and fatigue were conducted to identify the relationship between objective and subjective cognitive measures.

Results: 120 subjects with mean (±SD) age of 58.5 (±11.0) years were included. Sixty four percent were female, 82% were white, and 7% met criteria for major depressive disorder. Mean educational level was 15.3 (±2.2) years and disease duration was 19.9 (±11.1) years. Mean total cognitive impairment score was 2.5 (±2.2, range 0-10). The proportion of persons classified as cognitively impaired on each test ranged from 8% (semantic fluency test) to 28% (design fluency test). Mean PDQ score was 5.8 (±3.8, range 0-16). In the multivariate analysis, there was no significant relationship between PDQ score and total cognitive impairment score. However, depression and fatigue (ß=0.31, p<0.001; ß=0.32, p=0.001) were significantly associated with the PDQ score.

Conclusion: There was no significant relationship between perceived cognitive dysfunction and objective neuropsychological performance in this cohort. Depression and fatigue were significantly associated with perceived cognitive dysfunction. Findings emphasize the gap between subjective and objective measures of cognitive impairment and the importance of considering psychological factors in the context of cognitive complaints in clinical settings.


Disclosure:

S. Y. Shin,
None;

P. P. Katz,
None;

L. J. Julian,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-relationship-between-perceived-cognitive-dysfunction-and-objective-neuropsychological-performance-in-persons-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology